InvestorsHub Logo

TOB

Followers 162
Posts 5764
Boards Moderated 1
Alias Born 09/15/2010

TOB

Re: None

Sunday, 06/01/2014 12:17:44 PM

Sunday, June 01, 2014 12:17:44 PM

Post# of 1014

Investor misconceptions about Cynapsus have led to an incredible buying opportunity.

We believe the company's APL-130277 is a potential $700 million product.

Cynapsus recently raised $25 million in cash, enough to fund operations through the NDA filing.

Our DCF valuation pegs the shares at $2.25-2.50 right now, with upside to $4.50 on a take-out in 2016. Link to SA article